PROGNOSTIC FACTORS IN PATIENTS WITH RENAL-CELL CARCINOMA AND A ROLE OF ONCOPHAGE IN INCREASING SURVIVAL RATES AFTER SURGICAL TREATMENT

Por B. Ya. Alekseyev, G. A. Frank, Yu. Yu. Andreyeva, A. S. Kalpinsky
Publicado em 2009-06-01

Implication of expression of the oncoprotein Her-2/neu and the intracellular matrix component tenascin for metastatic activity of urinary bladder cancer

Por Yu. Yu. Andreyeva, L. E. Zavalishina, A. N. Petrov, G. A. Frank
Publicado em 2007-03-01

The role and assessment of morphological regression after neoadjuvant therapy in breast cancer patients

Por G A Frank, M E Ilatovskaia, Iu Iu Andreeva, L E Zavalishina
Publicado em 2015-06-01

Successful combined endoscopic treatment (photodynamic therapy+electrocautery) of patient with early cancer of lower third esophagus (14 year follow up)

Por V. V. Sokolov, Е. S. Karpova, Е. V. Filonenko, T. A. Belous, G. A. Frank
Publicado em 2013-03-01

Human papilloma virus DNA revelation in the superficial urothelial bladder carcinoma

Por U. U. Andreeva, L. E. Zavalishina, A. A. Morozov, I. G. Rusakov, G. A. Frank
Publicado em 2008-03-01

Primary multiple prostate and bladder cancer in patients undergone radical cystoprostatectomy

Por B. Ya. Alekseev, I. G. Rusakov, G. A. Frank, Yu. Yu. Andreeva, K. M. Nyushko
Publicado em 2005-06-01

Sravnitel'noe issledovanie opredeleniya HER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii

Por L E Zavalishina, Yu Yu Andreeva, A A Ryazantseva, M V Bateva, G A Frank
Publicado em 2009-06-01

THE RATE AND SITE OF LYMPH NODE METASTASES DURING RADICAL PROSTATECTOMY AND EXTENDED LYMPHADENECTOMY IN PATIENTS WITH PROSTATE CANCER

Por B. Ya. Alekseev, K. M. Nyushko, N. V. Vorobyev, A. S. Kalpinskiy, M. P. Golovashchenko, G. A. Frank, Yu. Yu. Andreeva
Publicado em 2012-03-01

Apoptosis and proliferation factors in renal cance

Por O. B. Loran, G. A. Frank, A. V. Seregin, L. E. Zavalishina, U. U. Andreeva, A. A. Seregin, N. A. Shustitzkiy
Publicado em 2008-06-01

HUMAN PAPILLOMAVIRUS AS A RISK FACTOR FOR BLADDER CANCER

Por G. M. Volgareva, G. A. Frank, D. A. Golovina, L. E. Zavalishina, Yu. Yu. Andreyeva, A. V. Khachaturyan, N. L. Cheban, V. B. Matveev
Publicado em 2010-12-01

HUMAN PAPILLOMAVIRUS AS A RISK FACTOR FOR BLADDER CANCER

Por G. M. Volgareva, G. A. Frank, D. A. Golovina, L. E. Zavalishina, Yu. Yu. Andreyeva, A. V. Khachaturyan, N. L. Cheban, V. B. Matveev
Publicado em 2014-08-01

Immunological heterogeneity of stage I breast cancer:biological, population-based and prognostic value (international cooperation experience)

Por I V Kolyadina, I V Poddubnaya, Cornelis JH Van de Velde, P JK Kuppen, G A Frank, D V Komov, A I Karseladze, E Bastiaannet, N G Dekker-Ensink
Publicado em 2015-03-01

Evolyutsiya ad\"yuvantnoy lekarstvennoyterapii «rannego» raka molochnoyzhelezy (mnogotsentrovoeissledovanie)

Por I V Kolyadina, I V Poddubnaya, G A Frank, D V Komov, A I Karseladze, V D Ermilova, Ya V Vishnevskaya, N P Makarenko, K A Teterin, S M Banov, Zh M Guzieva
Publicado em 2012-03-01